170 related articles for article (PubMed ID: 12495780)
21. Selective guanylyl cyclase inhibitor reverses nitric oxide-induced vasorelaxation.
Olson LJ; Knych ET; Herzig TC; Drewett JG
Hypertension; 1997 Jan; 29(1 Pt 2):254-61. PubMed ID: 9039111
[TBL] [Abstract][Full Text] [Related]
22. Functional characterization of nitric oxide and YC-1 activation of soluble guanylyl cyclase: structural implication for the YC-1 binding site?
Lamothe M; Chang FJ; Balashova N; Shirokov R; Beuve A
Biochemistry; 2004 Mar; 43(11):3039-48. PubMed ID: 15023055
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological characterisation of the relaxation induced by the soluble guanylate cyclase activator, BAY 60-2770 in rabbit corpus cavernosum.
Estancial CS; Rodrigues RL; De Nucci G; Antunes E; Mónica FZ
BJU Int; 2015 Oct; 116(4):657-64. PubMed ID: 25715977
[TBL] [Abstract][Full Text] [Related]
24. [YC-1-like potentiation of nitric oxide-dependent activation of soluble guanylyl cyclase by adrenochrome].
Severina IS; Piatakova NV; Shchegolev AIu; Sidorova TA
Biomed Khim; 2008; 54(6):679-86. PubMed ID: 19205427
[TBL] [Abstract][Full Text] [Related]
25. Soluble guanylyl cyclase: physiological role as an NO receptor and the potential molecular target for therapeutic application.
Nakane M
Clin Chem Lab Med; 2003 Jul; 41(7):865-70. PubMed ID: 12940510
[TBL] [Abstract][Full Text] [Related]
26. Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea-pig trachea.
Hwang TL; Wu CC; Teng CM
Br J Pharmacol; 1998 Nov; 125(6):1158-63. PubMed ID: 9863642
[TBL] [Abstract][Full Text] [Related]
27. Intracavernosal sildenafil facilitates penile erection independent of the nitric oxide pathway.
McAuley IW; Kim NN; Min K; Goldstein I; Traish AM
J Androl; 2001; 22(4):623-8. PubMed ID: 11451359
[TBL] [Abstract][Full Text] [Related]
28. Investigation of the role of the NO-cGMP pathway on YC-1 and DEA/NO effects on thoracic aorta smooth muscle responses in a rat preeclampsia model.
Turgut NH; Temiz TK; Turgut B; Karadas B; Parlak M; Bagcivan I
Can J Physiol Pharmacol; 2013 Oct; 91(10):797-803. PubMed ID: 24144050
[TBL] [Abstract][Full Text] [Related]
29. The guanylyl cyclase activator YC-1 directly inhibits the voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells.
Park WS; Ko JH; Ko EA; Son YK; Hong DH; Jung ID; Park YM; Choi TH; Kim N; Han J
J Pharmacol Sci; 2010; 112(1):64-72. PubMed ID: 20093789
[TBL] [Abstract][Full Text] [Related]
30. Optimizing nitric oxide production by time dependent L-arginine administration in isolated human corpus cavernosum.
Gur S; Kadowitz PJ; Trost L; Hellstrom WJ
J Urol; 2007 Oct; 178(4 Pt 1):1543-8. PubMed ID: 17707054
[TBL] [Abstract][Full Text] [Related]
31. Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3.
Delpy E; Coste H; Gouville AC
Br J Pharmacol; 1996 Oct; 119(3):471-8. PubMed ID: 8894166
[TBL] [Abstract][Full Text] [Related]
32. Soluble guanylyl cyclase activator YC-1 protects white matter axons from nitric oxide toxicity and metabolic stress, probably through Na(+) channel inhibition.
Garthwaite G; Goodwin DA; Neale S; Riddall D; Garthwaite J
Mol Pharmacol; 2002 Jan; 61(1):97-104. PubMed ID: 11752210
[TBL] [Abstract][Full Text] [Related]
33. BAY 41-2272: a stimulator of soluble guanylyl cyclase induces nitric oxide-dependent penile erection in vivo.
Bischoff E; Schramm M; Straub A; Feurer A; Stasch JP
Urology; 2003 Feb; 61(2):464-7. PubMed ID: 12597982
[TBL] [Abstract][Full Text] [Related]
34. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
[TBL] [Abstract][Full Text] [Related]
35. In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway.
Fedele E; Jin Y; Varnier G; Raiteri M
Br J Pharmacol; 1996 Oct; 119(3):590-4. PubMed ID: 8894183
[TBL] [Abstract][Full Text] [Related]
36. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
Nimmegeers S; Sips P; Buys E; Brouckaert P; Van de Voorde J
Cardiovasc Res; 2007 Oct; 76(1):149-59. PubMed ID: 17610859
[TBL] [Abstract][Full Text] [Related]
37. Nitric oxide independent activation of guanylate cyclase by YC-1 causes erectile responses in the rat.
Mizusawa H; Hedlund P; Brioni JD; Sullivan JP; Andersson KE
J Urol; 2002 May; 167(5):2276-81. PubMed ID: 11956492
[TBL] [Abstract][Full Text] [Related]
38. Relaxant effects of the soluble guanylate cyclase activator and NO sensitizer YC-1 in piglet pulmonary arteries.
González-Luis G; Cogolludo A; Moreno L; Lodi F; Tamargo J; Pérez-Vizcaíno F; Villamor E
Biol Neonate; 2006; 90(1):66-72. PubMed ID: 16534188
[TBL] [Abstract][Full Text] [Related]
39. Blockade of nitrergic neuroeffector transmission in guinea-pig colon by a selective inhibitor of soluble guanylyl cyclase.
Olgart C; Hallén K; Wiklund NP; Iversen HH; Gustafsson LE
Acta Physiol Scand; 1998 Jan; 162(1):89-95. PubMed ID: 9492906
[TBL] [Abstract][Full Text] [Related]
40. Comparative effects of activation of soluble and particulate guanylyl cyclase on cyclic GMP elevation and relaxation of bovine tracheal smooth muscle.
Ijioma SC; Challiss RA; Boyle JP
Br J Pharmacol; 1995 Jul; 115(5):723-32. PubMed ID: 8548169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
